Monday, September 28, 2009

UAE firm gets nod for swine flu medicine production

Abu Dhabi-based drug manufacturer Neopharma today said it has received clearance from the UAE Ministry of Health for the production of an antiviral medication Oseltamivir BR Flu.

The approval comes at a time when the entire region is stepping up efforts to tackle the swine flu pandemic, and it is being considered as a potential choice to prevent and treat the disease.

Neopharma, Vice-Chairman, Abdulla Humaid Al Mazroei and Managing Director and CEO, Dr BR Shetty thanked the Health Ministry on behalf of the Board of Directors of the company.

"As a leading manufacturer of life-saving drugs, we believe it is our responsibility to play a vital role in helping the community at this critical juncture. We are confident the approval for Oseltamivir will significantly facilitate medical professionals and the wider community to effectively combat the lethal H1N1 virus in the region," Dr Shetty said.

No comments:

Post a Comment